Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythematosus

Area of Science:

• Pediatric Rheumatology
• Immunology
• Biomarker Discovery

Background:

• Juvenile systemic lupus erythematosus (JSLE) presents with earlier onset and increased severity compared to adult-onset SLE.
• Current JSLE management often extrapolates from adult data, necessitating specific pediatric biomarkers.
• Identifying JSLE-specific biomarkers can improve disease understanding, patient management, and outcomes.

Purpose of the Study:

• To review and appraise the clinical utility of traditional and novel biomarkers in JSLE.
• To focus on biomarkers predicting specific organ involvement, particularly renal disease.
• To emphasize research on cardiovascular, neurological, hematological, skin, and joint biomarkers, including genetic markers.

Main Methods:

• This is a narrative review.
• Evidence synthesis of traditional and novel biomarkers in JSLE.
• Focus on biomarkers related to specific organ manifestations and genetic factors.

Main Results:

• Various biomarkers show promise in identifying and predicting organ involvement in JSLE.
• Renal biomarkers are a key focus, with ongoing research into cardiovascular, neurological, hematological, skin, and joint manifestations.
• Genetic biomarkers are also being explored for potential clinical applications in JSLE.

Conclusions:

• Biomarker research is vital for tailoring management strategies in JSLE.
• Identifying specific biomarkers can lead to earlier diagnosis, better prediction of organ damage, and improved patient outcomes in pediatric lupus.
• Further research into diverse biomarkers, including genetic factors, is essential for advancing JSLE care.